Antimicrobial Constituents of the Leaves of Mikania micrantha H. B. K

Yan Li, Jun Li, Yuan Li, Xiaxia Wang, Aocheng CaoPLoS 2013 · DOI

Abstract

The leaves of M. micrantha may be a promising source in the search for new antimicrobial drugs due to its efficacy and broad spectrum of activity. By identifying these bioactive constituents, the adverse ecological impact of this invasive species can be mitigated through economic utilization.

Introduction

Mikania micrantha, commonly known as the "mile-a-minute weed," is one of the world's most destructive invasive species. Since its introduction to South China and Southeast Asia in the 1980s, it has significantly disrupted local ecosystems and agricultural productivity by smothering native vegetation. While traditional folk medicine has utilized Mikania species (often called "guaco") for treating infections and snake bites, the specific chemical constituents responsible for these properties remained largely unidentified. This research aims to isolate these active molecules and evaluate their potential as broad-spectrum antimicrobial agents.

Methods

The study employed a bioactivity-guided fractionation approach to isolate the antimicrobial compounds from air-dried leaves.

  1. Extraction & Isolation: Leaves were extracted using chloroform, and the crude residue was separated via silica gel column chromatography.
  2. Structural Characterization: Molecular structures were determined using 1D and 2D Nuclear Magnetic Resonance (NMR), Infrared (IR) spectroscopy, and High-Resolution Electrospray Ionization Mass Spectrometry (HRESIMS).
  3. Structural Confirmation: For the novel compounds, single-crystal X-ray diffraction was used to provide definitive 3D maps of the atoms and stereochemistry.
  4. Biological Assays: Compounds were tested for Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) against bacteria, and $EC_{50}$ (half-maximal effective concentration) against fungi.

Biological Targets

The isolated compounds were tested against a diverse panel of 16 pathogens:

  • 8 Plant Pathogenic Fungi: Including species responsible for corn leaf blight, anthracnose, and root rot.
  • 4 Plant Pathogenic Bacteria: Such as Ralstonia solanacearum (bacterial wilt).
  • 4 Gram-Positive Bacteria: Including Staphylococcus aureus and Bacillus subtilis.

Chemical Novelty and Structural Insights

The research successfully isolated six bioactive compounds, including three entirely new sesquiterpene lactones: deoxymikanolide (1), scandenolide (2), and dihydroscandenolide (3).

Chemical structures of the six isolated compounds (1-6) from M. micrantha.

All five isolated lactones share a "guaianolide" skeleton, which is believed to be the primary driver of their antimicrobial efficacy. Deoxymikanolide (Compound 1) emerged as the most potent isolate, particularly in inhibiting fungal spore germination, a critical stage in the spread of plant diseases.

Key Results

  • Antibacterial Potency: Deoxymikanolide exhibited MIC values between 62.5 and 125 mg/L across all tested bacteria, outperforming other isolates which generally required up to 500 mg/L.
  • Antifungal Efficacy: In spore germination assays, deoxymikanolide achieved an $IC_{50}$ of 21.44 mg/L against Exserohilum turcicum (a major corn pathogen).
  • Broad Spectrum: The compounds demonstrated activity against both Gram-positive and Gram-negative bacteria, as well as various fungal phyla, suggesting potential for versatile agricultural and pharmaceutical applications.

Conclusion and Future Work

By identifying high-value pharmaceutical uses for M. micrantha, this research provides an economic incentive for its harvest and control, potentially turning an ecological threat into a resource. However, several challenges remain:

  • Solubility: The sesquiterpene lactones have low water solubility, necessitating chemical modifications like hydrolysis for practical application in liquid sprays.
  • Mechanism of Action: Further study is required to understand the molecular mechanisms (e.g., membrane disruption vs. protein synthesis inhibition).
  • Field Trials: Future work must transition from in vitro lab results to greenhouse and field trials to confirm stability and efficacy in real-world environments.

Summary updated

Abstract

The leaves of M. micrantha may be a promising source in the search for new antimicrobial drugs due to its efficacy and the broadest range. Meanwhile, adverse impact of M. micrantha will be eliminated.
BibTeX
@inproceedings{li2013antimicrobial,
  author = {Yan Li and Jun Li and Yuan Li and Xiaxia Wang and Aocheng Cao},
  title = {{Antimicrobial Constituents of the Leaves of Mikania micrantha H. B. K}},
  booktitle = {PLoS},
  year = {2013},
  doi = {10.1371/journal.pone.0076725},
}
Figure